SET and lung adenocarcinoma: To examine if P-FTY720 is involved in targeting I2PP2A/SET leading to tumour growth inhibition in vivo, we implanted Lewis lung adenocarcinoma cell (LLC)-derived allografts in the flanks of SK-2−/− compared to WT mice and treated with oral doses of 10 mg/kg FTY720.